Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn's Disease

Inflamm Bowel Dis. 2021 Oct 18;27(10):e124. doi: 10.1093/ibd/izab115.
No abstract available

Keywords: anti-TNF therapy; biologic therapy; cutaneous Crohn’s disease; dermatologic manifestation; ustekinumab.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antibodies, Monoclonal, Humanized* / ultrastructure
  • Crohn Disease* / drug therapy
  • Humans
  • Remission Induction
  • Skin Diseases*
  • Ustekinumab* / therapeutic use

Substances

  • Antibodies, Monoclonal, Humanized
  • Ustekinumab